Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts

Published:2017-07 Issue:7 Volume:28 Page:1427-1435
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Boonstra P.S.,Braun T.M.,Taylor J.M.G.,Kidwell K.M.,Bellile E.L.,Daignault S.,Zhao L.,Griffith K.A.,Lawrence T.S.,Kalemkerian G.P.,Schipper M.J.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/7/1427/24169463/mdx045.pdf

Reference35 articles.

1. Evolution of clinical trial design in early drug development: systematic review of expansion cohort use in single-agent phase I cancer trials;Manji;J Clin Oncol,2013

2. Evaluation of statistical designs in phase I expansion cohorts: the Dana-Farber/Harvard Cancer Center experience;Dahlberg;J Natl Cancer Inst,2014

3. Design considerations for dose-expansion cohorts in phase I trials;Iasonos;J Clin Oncol,2013

4. A statistical evaluation of dose expansion cohorts in phase I clinical trials;Boonstra;J Natl Cancer Inst,2015

5. Building firm foundations for therapy development;Dignam;J Natl Cancer Inst,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the doses of cancer drugs after usual dose finding;Clinical Trials;2023-12-27

2. Early phase clinical trial played a critical role in the Food and Drug Administration–approved indications for targeted anticancer drugs: a cross-sectional study from 2012 to 2021;Journal of Clinical Epidemiology;2023-05

3. A modular framework for early-phase seamless oncology trials;Clinical Trials;2021-01-21

4. Ethical and Policy Issues for Seamless Phase I Oncology Trials;Journal of Clinical Oncology;2020-03-01

5. Sequential or combined designs for Phase I/II clinical trials? A simulation study;Clinical Trials;2019-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3